HCW Biologics Company

HCW Biologics is developing immunotherapies to lengthen healthspan by disrupting the link between cellular senescence and disease.
Technology: Geroscience
Industry: Others
Headquarters: United States
Founded Date: 2018-04-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 2
Total Funding: $18.1M
Estimated Revenue: $1M to $10M
Last Funding Type: Series B

Visit Website
Register and Claim Ownership